Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc.HRGN · Entity 7501 | 10% owner | July 08, 2024 | August 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Harvard Apparatus Regenerative Technology, Inc.
Report date July 08, 2024 · Filed August 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2026-06-17 | Direct | 25,000 |
Reported balance
After 2024-07-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-07-08 · Other · Acquired 50,000 · Balance 25,000 F1: These warrants were transferred by the Reporting Person to two unaffiliated persons. |
| Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2026-06-17 | Direct | 0 |
Reported balance
After 2024-07-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-07-31 · Other · Acquired 25,000 · Balance 0 F2: These warrants were transferred by the Reporting Person to one unaffiliated person. |
| Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2026-09-01 | Direct | 0 |
Reported balance
After 2024-07-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-07-31 · Other · Acquired 140,000 · Balance 0 F1: These warrants were transferred by the Reporting Person to two unaffiliated persons. |
| Common StockSEC Table I · non-derivative | Direct | 3,725,825 |
Reported balance
Holding disclosure · report date 2024-07-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,725,825 |
| Common StockSEC Table I · non-derivative | IndirectOwned by sole member of reporting person | 30,722 |
Reported balance
Holding disclosure · report date 2024-07-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 30,722 |
Filing footnotes · ownership attribution and instrument terms
F1: These warrants were transferred by the Reporting Person to two unaffiliated persons.
F2: These warrants were transferred by the Reporting Person to one unaffiliated person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2024 Filed Aug 7, 2024 22:29 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | OtherWarrants (right to buy) · Derivative | 140,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001493152-24-030621 · ownership.xml · derivative · entry 5 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 140,000 shares Expires 2026-09-01 F1 · kind: These warrants were transferred by the Reporting Person to two unaffiliated persons. Read SEC document |
| July 31, 2024 Filed Aug 7, 2024 22:29 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | OtherWarrants (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001493152-24-030621 · ownership.xml · derivative · entry 4 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2026-06-17 F2 · kind: These warrants were transferred by the Reporting Person to one unaffiliated person. Read SEC document |
| July 08, 2024 Filed Aug 7, 2024 22:29 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | OtherWarrants (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001493152-24-030621 · ownership.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 50,000 shares Expires 2026-06-17 F1 · kind: These warrants were transferred by the Reporting Person to two unaffiliated persons. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:00 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrants (right to buy) · Derivative | 110,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001493152-23-011747 · ownership.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 110,000 shares Expires 2026-09-01 F2 · kind: These warrants were transferred by the Reporting Person to two unaffiliated persons. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:00 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 62,500 | $6.00 | $375,000.00 |
DisclosureSEC source: 0001493152-23-011747 · ownership.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,725,825 F1 · price: On March 31, 2023, the Issuer and the Reporting Person entered into a securities purchase agreement pursuant to which on April 6, 2023 the Reporting Person acquired 62,500 shares of the Issuer's common stock, $0.01 par value (the "Shares") from the Issuer in a private placement. The aggregate subscription amount paid by the Reporting Person for the Shares was $375,000. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrants (right to buy) · Derivative | 7,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012350 · form4-12092022_101229.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2022-12-27 F1 · kind: On December 7, 2022, the Reporting Person exercised a warrant to purchase 7,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 1,952 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 5,048 shares of common stock. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | SaleCommon Stock | 1,952 | $7.17 | $13,995.84 |
DisclosureSEC source: 0001415889-22-012350 · form4-12092022_101229.xml · nonDerivative · entry 2 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,663,325 F1 · kind: On December 7, 2022, the Reporting Person exercised a warrant to purchase 7,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 1,952 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 5,048 shares of common stock. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherCommon Stock | 7,000 | $2.00 | $14,000.00 |
DisclosureSEC source: 0001415889-22-012350 · form4-12092022_101229.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,665,277 Read SEC document |
| May 12, 2022 Filed May 20, 2022 00:47 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseWarrants (right to buy) · Derivative | 4,139 | Not disclosed Strike: $8.88 | Not disclosed |
DisclosureSEC source: 0001104659-22-063025 · tm2216158-1_4seq1.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,139 Underlying: Common Stock · 4,139 shares Expires 2027-05-12 F1 · kind: On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 8,277 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 4,139 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $49,000. F1 · price: On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 8,277 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 4,139 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $49,000. Read SEC document |
| May 12, 2022 Filed May 20, 2022 00:47 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 8,277 | $5.92 | $48,999.84 |
DisclosureSEC source: 0001104659-22-063025 · tm2216158-1_4seq1.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658,277 F1 · price: On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 8,277 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 4,139 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $49,000. Read SEC document |
| September 01, 2021 Filed Sep 9, 2021 23:13 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseWarrant (right to buy) · Derivative | 250,000 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0001104659-21-114301 · tm2127249-1_4seq1.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2026-09-01 F1 · kind: On September 1, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 500,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 250,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $1,000,000. F1 · price: On September 1, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 500,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 250,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $1,000,000. Read SEC document |
| September 01, 2021 Filed Sep 9, 2021 23:13 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 500,000 | $2.00 | $1,000,000.00 |
DisclosureSEC source: 0001104659-21-114301 · tm2127249-1_4seq1.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,650,000 F1 · price: On September 1, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 500,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 250,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $1,000,000. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:30 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseWarrant (right to buy) · Derivative | 75,000 | Not disclosed Strike: $2.00 | Not disclosed |
DisclosureSEC source: 0001104659-21-083662 · tm2115117d1_4.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2026-06-17 F1 · kind: On June 17, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 150,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 75,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $300,000. F1 · price: On June 17, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 150,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 75,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $300,000. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:30 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 150,000 | $2.00 | $300,000.00 |
DisclosureSEC source: 0001104659-21-083662 · tm2115117d1_4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,150,000 F1 · price: On June 17, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 150,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 75,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $300,000. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 23:54 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001104659-20-105351 · tm2030917-1_4.xml · derivative · entry 4 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 100,000 shares Expires 2022-12-27 F1 · kind: These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 23:54 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001104659-20-105351 · tm2030917-1_4.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,000 Underlying: Common Stock · 100,000 shares Expires 2022-12-27 F1 · kind: These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| March 20, 2020 Filed Sep 15, 2020 23:54 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001104659-20-105351 · tm2030917-1_4.xml · derivative · entry 2 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,000 Underlying: Common Stock · 100,000 shares Expires 2022-12-27 F1 · kind: These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| March 09, 2020 Filed Sep 15, 2020 23:54 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 51,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001104659-20-105351 · tm2030917-1_4.xml · derivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,000 Underlying: Common Stock · 51,500 shares Expires 2022-12-27 F1 · kind: These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| January 31, 2020 Filed Feb 6, 2020 22:13 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 62,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012024 · tm207017-1_4s.xml · derivative · entry 2 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,500 Underlying: Common Stock · 62,500 shares Expires 2022-12-27 F1 · kind: These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| December 31, 2019 Filed Feb 6, 2020 22:13 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 94,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001104659-20-012024 · tm207017-1_4s.xml · derivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,000 Underlying: Common Stock · 94,000 shares Expires 2022-12-27 F1 · kind: These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| December 04, 2019 Filed Dec 6, 2019 21:16 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001104659-19-070595 · tm1924689-1_4.xml · derivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,000 Underlying: Common Stock · 200,000 shares Expires 2022-12-27 F1 · kind: These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:38 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001144204-19-046967 · tv530555_4.xml · derivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 715,000 Underlying: Common Stock · 30,000 shares Expires 2022-12-27 F1 · kind: These warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 21:07 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001144204-19-043446 · tv528899_4.xml · derivative · entry 2 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 745,000 Underlying: Common Stock · 40,000 shares Expires 2022-12-27 F1 · kind: These Warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| August 30, 2019 Filed Sep 4, 2019 21:07 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 555,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001144204-19-043446 · tv528899_4.xml · derivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 785,000 Underlying: Common Stock · 555,000 shares Expires 2022-12-27 F1 · kind: These Warrants were transferred by the Reporting Person on the condition that the assignee immediately exercise the Warrants for cash. Read SEC document |
| May 03, 2019 Filed May 13, 2019 21:25 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 250,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001144204-19-025682 · tv521254_4.xml · derivative · entry 5 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,340,000 Underlying: Common Stock · 250,000 shares Expires 2022-12-27 Read SEC document |
| May 03, 2019 Filed May 13, 2019 21:25 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherCommon Stock | 250,000 | $2.00 | $500,000.00 |
DisclosureSEC source: 0001144204-19-025682 · tv521254_4.xml · nonDerivative · entry 2 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Read SEC document |
| April 24, 2019 Filed May 13, 2019 21:25 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 250,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001144204-19-025682 · tv521254_4.xml · derivative · entry 4 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,590,000 Underlying: Common Stock · 250,000 shares Expires 2022-12-27 Read SEC document |
| April 24, 2019 Filed May 13, 2019 21:25 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherCommon Stock | 250,000 | $2.00 | $500,000.00 |
DisclosureSEC source: 0001144204-19-025682 · tv521254_4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,750,000 Read SEC document |
| January 31, 2019 Filed Feb 20, 2019 22:13 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherWarrant (right to buy) · Derivative | 500,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001144204-19-009141 · tv514164_form4.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,840,000 Underlying: Common Stock · 500,000 shares Expires 2022-12-27 Read SEC document |
| January 31, 2019 Filed Feb 20, 2019 22:13 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | OtherCommon Stock | 500,000 | $2.00 | $1,000,000.00 |
DisclosureSEC source: 0001144204-19-009141 · tv514164_form4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500,000 Read SEC document |
| July 12, 2018 Filed Jul 17, 2018 01:55 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 5,000 | $4.00 | $20,000.00 |
DisclosureSEC source: 0001144204-18-038587 · tv498677_4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by sole member of reporting person Disclosed balance after: 30,722 Read SEC document |
| June 29, 2018 Filed Jul 6, 2018 21:18 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | ConversionSeries D Convertible Preferred Stock · Derivative | 3,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001144204-18-037568 · tv498154_form4.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: The shares of Series D Convertible Preferred Stock have no expiration date. Read SEC document |
| June 29, 2018 Filed Jul 6, 2018 21:18 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | ConversionCommon Stock | 1,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-037568 · tv498154_form4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of common stock received upon conversion of Series D Convertible Preferred Stock. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:31 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 10,000 | $3.26 | $32,600.00 |
DisclosureSEC source: 0001144204-18-012556 · tv487576_4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by sole member of reporting person Disclosed balance after: 25,722 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.016 to $3.30, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 22, 2018 Filed Jan 23, 2018 23:40 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 1,572 | $2.67 | $4,197.24 |
DisclosureSEC source: 0001144204-18-003347 · tv483929_4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by sole member of reporting person Disclosed balance after: 15,722 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.594 to $2.70, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 19, 2018 Filed Jan 22, 2018 21:22 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 3,700 | $2.60 | $9,620.00 |
DisclosureSEC source: 0001144204-18-003086 · tv483793_form4.xml · nonDerivative · entry 2 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by sole member of reporting person Disclosed balance after: 14,150 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.5999 to $2.60, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 17, 2018 Filed Jan 22, 2018 21:22 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 5,000 | $2.20 | $11,000.00 |
DisclosureSEC source: 0001144204-18-003086 · tv483793_form4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by sole member of reporting person Disclosed balance after: 10,450 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.152 to $2.20, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 21:15 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 5,000 | $2.16 | $10,800.00 |
DisclosureSEC source: 0001144204-18-002289 · tv483371_form4.xml · nonDerivative · entry 2 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by sole member of reporting person Disclosed balance after: 5,450 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.04 to $2.19, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 21:15 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | PurchaseCommon Stock | 200 | $1.90 | $380.00 |
DisclosureSEC source: 0001144204-18-002289 · tv483371_form4.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by sole member of reporting person Disclosed balance after: 450 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.